McKesson Leads Investment in Community Pharmacy Ownership
IRVING, Texas, Oct. 17, 2019 —The McKesson RxOwnership® team has partnered with the National Community Pharmacists Association (NCPA) to sponsor its tenth annual Ownership Workshop series, to cultivate community pharmacy ownership. The next Ownership Workshop takes place Oct. 24-26, 2019, ahead of th... (Source: McKesson News)
Source: McKesson News - October 17, 2019 Category: Information Technology Source Type: news
McKesson and Aetion Collaborate to Advance Cancer Research with Real-World Data
IRVING, Texas and NEW YORK, Oct. 15, 2019 — Today Aetion and McKesson announced a strategic collaboration focused on advancing the use of real-world evidence (RWE) in cancer research to benefit patients, regulators, the biopharma industry, and payers. The partnership will provide best-in-class solut... (Source: McKesson News)
Source: McKesson News - October 15, 2019 Category: Information Technology Source Type: news
Fifteen Practices in The US Oncology Network Earn High-Quality Performance Ratings in the Oncology Care Model, Saving Medicare $35 Million
THE WOODLANDS, Texas, Oct. 8, 2019 — The Centers for Medicare& Medicaid Innovation (CMMI) recently released results for the fourth performance period of the Oncology Care Model (OCM), and all 15 practices in The US Oncology Network (The Network) participating in the program earned high marks for qu... (Source: McKesson News)
Source: McKesson News - October 8, 2019 Category: Information Technology Source Type: news
McKesson Launches Strategic Planning Solution for Community-Based Oncology Customers
IRVING, Texas, Oct. 4, 2019 — A new strategic planning solution for oncology practices is now available to customers through McKesson’s Business Advisory Services, a team of experts dedicated to helping specialty practices solve financial and operational challenges through consulting, analytics and ... (Source: McKesson News)
Source: McKesson News - October 4, 2019 Category: Information Technology Source Type: news
McKesson and Augmedix Expand Collaboration to Enhance the Doctor-Patient Relationship
IRVING, Texas and SAN FRANCISCO, Oct. 3, 2019 —McKesson Corporation, which has been investing in technologies and services that create greater efficiencies for healthcare providers, announced an expansion to its collaboration with Augmedix. (Source: McKesson News)
Source: McKesson News - October 3, 2019 Category: Information Technology Source Type: news
McKesson Corporation to Announce Second Quarter Fiscal 2020 Results on October 30, 2019
IRVING, TEXAS —September 30, 2019—McKesson Corporation (NYSE:MCK) announced today that its second quarter fiscal 2020 financial results will be released before market open on Wednesday, October 30, 2019. The company will host a conference call at 8:00 AM Eastern Time to discuss the financial results. (Source: McKesson News)
Source: McKesson News - September 30, 2019 Category: Information Technology Source Type: news
AMP: Access for More Patients Transforms Patient Access to Specialty Medications
IRVING, Texas, Sept. 25, 2019 —RxCrossroads by McKesson and CoverMyMeds today announced the launch of AMP: Access for More Patients™, a first-in-class, technology-driven patient support solution that transforms how patients access, afford and adhere to their medications. Designed to automate access t... (Source: McKesson News)
Source: McKesson News - September 25, 2019 Category: Information Technology Source Type: news
McKesson and TrakCel Launch Innovative Collaboration to Support Commercialization of Cell and Gene Therapies
IRVING, Texas, US and CARDIFF, UK, Sept. 11, 2019 —McKesson, a leading provider of third-party logistic (3PL) services, patient access support and specialty pharmacy solutions, and TrakCel, the software developer for cell and gene therapy supply chain tracking and orchestration systems, today announc... (Source: McKesson News)
Source: McKesson News - September 11, 2019 Category: Information Technology Source Type: news
Blue Cross and Blue Shield of Minnesota and Minnesota Oncology Announce Five-Year Collaboration
ST. PAUL, Minn., Aug. 22, 2019 — Blue Cross and Blue Shield of Minnesota (Blue Cross) and Minnesota Oncology, a practice in The US Oncology Network, today announced a five-year agreement that will change the way cancer care is paid for and managed in order to deliver optimal health outcomes at lower... (Source: McKesson News)
Source: McKesson News - August 22, 2019 Category: Information Technology Source Type: news
McKesson Playing Pivotal Role in Phase II of Friends of Cancer Research Real-World Evidence Initiative
IRVING, Texas, August 8, 2019 —McKesson is pleased to announce that it is participating in Phase II of the Friends of Cancer Research (Friends) Real-World Evidence (RWE) pilot project to advance the understanding and inform future uses of RWE. (Source: McKesson News)
Source: McKesson News - August 8, 2019 Category: Information Technology Source Type: news
TURALIO (pexidartinib), FDA Approved Treatment of TGCT, Available at Biologics by McKesson
CARY, N.C. (August 7, 2019) — Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, was selected by Daiichi Sankyo, Inc. as the exclusive specialty pharmacy provider for TURALIO™ (pexidartinib) for the treatment of adult patients with symptomatic ... (Source: McKesson News)
Source: McKesson News - August 7, 2019 Category: Information Technology Source Type: news
NUBEQA (darolutamide), FDA Approved for Treatment of High-Risk Non-Metastatic Prostate Cancer, Available at Biologics by McKesson
CARY, N.C., August 1, 2019 —Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, was selected by Bayer HealthCare as a specialty pharmacy provider for NUBEQA® (darolutamide) for the treatment of non-metastatic castration-resistant prostate cancer ... (Source: McKesson News)
Source: McKesson News - August 1, 2019 Category: Information Technology Source Type: news
McKesson Reports Fiscal 2020 First-Quarter Results
First-quarter fiscal 2020 revenues of $55.7 billion, an increase of 6%.First-quarter GAAP earnings per diluted share from continuing operations of $2.27, up 429% year over year.First-quarter Adjusted Earnings per diluted share of $3.31, up 14% year over year. Raised fiscal 2020 Adjusted EPS guidance... (Source: McKesson News)
Source: McKesson News - July 31, 2019 Category: Information Technology Source Type: news
McKesson Opens New Distribution Center in Seattle Area
PUYALLUP, Wash., July 25, 2019 — McKesson Corporation has opened a new distribution center in Puyallup, Washington – 35 miles south of Seattle. Positioned on six acres, the 118,500-square-foot facility, includes a distribution center and office space and will service hospitals, health systems, commu... (Source: McKesson News)
Source: McKesson News - July 25, 2019 Category: Information Technology Source Type: news
McKesson Named One of the Best Places to Work for Disability Inclusion
For the fourth year in a row, McKesson was named a ‘Best Place to Work’ for Disability Inclusion. McKesson earned a top-ranking score of 100 on the 2019 Disability Equality Index®(DEI), a joint initiative of the American Association of People with Disabilities (AAPD) and Disability:IN. (Source: McKesson News)
Source: McKesson News - July 17, 2019 Category: Information Technology Source Type: news
